Literature DB >> 6759075

Insulin treatment reverses the insulin resistance of type II diabetes mellitus.

J A Scarlett, R S Gray, J Griffin, J M Olefsky, O G Kolterman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6759075     DOI： 10.2337/diacare.5.4.353

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  37 in total

1.  Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus.

Authors:  W T Garvey; T P Huecksteadt; S Matthaei; J M Olefsky
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 2.  Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy.

Authors:  Louis Kuritzky
Journal:  MedGenMed       Date:  2006-11-15

Review 3.  Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status.

Authors:  M B Davidson
Journal:  West J Med       Date:  1985-02

4.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

Authors:  J P Hosker; D R Matthews; A S Rudenski; M A Burnett; P Darling; E G Bown; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?

Authors:  I Peacock; R B Tattersall
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-30

7.  Infusion of insulin impairs human adipocyte glucose metabolism in vitro without decreasing adipocyte insulin receptor binding.

Authors:  L Mandarino; B Baker; R Rizza; J Genest; J Gerich
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

8.  Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and Type 2 (non-insulin-dependent) diabetic patients.

Authors:  E Standl; H J Kolb
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

Review 9.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

10.  Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.

Authors:  Aurora Merovci; Carolina Solis-Herrera; Giuseppe Daniele; Roy Eldor; Teresa Vanessa Fiorentino; Devjit Tripathy; Juan Xiong; Zandra Perez; Luke Norton; Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.